Eli Lilly vows to extend public&s grant access globally

Share this article:
Eli Lilly, the first drug company to make data on its US educational grants accessible to the public, vowed to extend the policy globally by 2008. Meanwhile, it published its second full quarter of grants online.

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.